New study brings genetic testing to newborns in underserved texas hospitals

NCT ID NCT07102966

Recruiting now Diagnosis Sponsor: Baylor College of Medicine Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study offers rapid whole genome sequencing and virtual genetic consultations to 200 seriously ill newborns in Texas hospitals with limited resources, especially along the Texas-Mexico border. Researchers want to see if the virtual tool, Consultagene, helps doctors diagnose rare genetic diseases faster than usual care. Feedback from healthcare providers will also be collected to improve the tool.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: rapid whole genome sequencing
What this could lead to: If successful, this could show that rapid genetic testing and virtual consultations help diagnose rare diseases faster in newborns, especially in underserved areas.
What could go wrong: This is an early-stage study with only 200 infants, so results may not apply to all newborns. The virtual tool may not work as well as in-person care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GENETIC DISORDERS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hereditary disease Rare Diseases

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

RARE DISEASES

Contacts and locations

Locations

Baylor College of Medicine
RECRUITING

Houston, Texas, 77030, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.